Merck seeks to escape Baltimore’s vaccine bundling lawsuit
The City of Baltimore cannot allege that Merck’s bundled discounts for paediatric rotavirus vaccines harmed competition because its main rival still has every ability to compete, the drugmaker has said.
Subscribe to Global Competition Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10